Physician profile
Scott Schlidt
NPI 1063463719
$2,808.57
in general payments reported to CMS, 2019-2025
10 companies · $634 in 2025
The $634 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $158 · 2021: $513 · 2022: $330 · 2023: $113 · 2024: $590 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,335.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,093.99 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $519.69 | 2020-2024 | Impella |
| Getinge USA Sales, LLC | $475.52 | 2019-2025 | Heartstring III Proximal Seal, Acrobat-I Stabilizer, Vasoview Hemopro 2 |
| Boston Scientific Corporation | $252.88 | 2021-2022 | |
| Medtronic Vascular, INC. | $198.48 | 2019 | |
| Medtronic, INC. | $172.03 | 2021-2025 | Octopus, Mosaic, Corevalve Evolut R |
| Bolton Medical INC | $36.87 | 2025 | Treo Abdominal Stent-Graft System |
| Kci USA, INC. | $21.90 | 2019 | |
| Livanova USA, INC. | $19.99 | 2019 | |
| Lsi Solutions INC | $17.22 | 2024 | Cor-Knot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Schlidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.